NO20001459L - Anvendelse av kombinasjoner som innbefatter ikke-sedative antihistaminer og <alfa>-adrenerge legemidler for topisk behandling av rhinitt/konjunktivitt og forkjølelse, forskjølelseslignende og/eller influensasymptomer - Google Patents

Anvendelse av kombinasjoner som innbefatter ikke-sedative antihistaminer og <alfa>-adrenerge legemidler for topisk behandling av rhinitt/konjunktivitt og forkjølelse, forskjølelseslignende og/eller influensasymptomer

Info

Publication number
NO20001459L
NO20001459L NO20001459A NO20001459A NO20001459L NO 20001459 L NO20001459 L NO 20001459L NO 20001459 A NO20001459 A NO 20001459A NO 20001459 A NO20001459 A NO 20001459A NO 20001459 L NO20001459 L NO 20001459L
Authority
NO
Norway
Prior art keywords
colds
conjunctivitis
flu
rhinitis
symptoms
Prior art date
Application number
NO20001459A
Other languages
English (en)
Other versions
NO20001459D0 (no
Inventor
Maria Del Carmen Diez Crespo
Roberto Mainardi
Istvan Szelenyi
Reinhard Muckenschnabel
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of NO20001459L publication Critical patent/NO20001459L/no
Publication of NO20001459D0 publication Critical patent/NO20001459D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20001459A 1997-09-22 2000-03-21 Anvendelse av kombinasjoner som innbefatter ikke-sedative antihistaminer og <alfa>-adrenerge legemidler for topisk behandling av rhinitt/konjunktivitt og forkjølelse, forskjølelseslignende og/eller influensasymptomer NO20001459D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97116494A EP0903151A1 (en) 1997-09-22 1997-09-22 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
PCT/EP1998/005795 WO1999015203A1 (en) 1997-09-22 1998-09-11 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms

Publications (2)

Publication Number Publication Date
NO20001459L true NO20001459L (no) 2000-03-21
NO20001459D0 NO20001459D0 (no) 2000-03-21

Family

ID=8227389

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001459A NO20001459D0 (no) 1997-09-22 2000-03-21 Anvendelse av kombinasjoner som innbefatter ikke-sedative antihistaminer og <alfa>-adrenerge legemidler for topisk behandling av rhinitt/konjunktivitt og forkjølelse, forskjølelseslignende og/eller influensasymptomer

Country Status (12)

Country Link
US (1) US20020037297A1 (no)
EP (1) EP0903151A1 (no)
JP (1) JP2001517639A (no)
AU (1) AU9540098A (no)
BR (1) BR9812361A (no)
CA (1) CA2304162A1 (no)
DE (1) DE19882573T1 (no)
ES (1) ES2171356B2 (no)
NO (1) NO20001459D0 (no)
PL (1) PL339541A1 (no)
WO (1) WO1999015203A1 (no)
ZA (1) ZA988638B (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
WO2001078782A1 (en) * 2000-04-14 2001-10-25 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
AU2001269672A1 (en) * 2000-10-05 2002-04-15 Unimed Pharma Spol. S.R.O. Eye instillation with decongestant effect
US20020094345A1 (en) 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
PE20020324A1 (es) * 2000-10-06 2002-06-18 Boehringer Ingelheim Int Nuevas composiciones farmaceuticas que contienen epinastina y pseudoefedrina
FR2833493B1 (fr) * 2001-12-18 2005-09-23 Ioltechnologie Production Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble
EP1327463A1 (de) * 2002-01-04 2003-07-16 Oramon Arzneimittel GmbH Gel enthaltend Cetirizin und Loratadin zur topischen Anwendung
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
NZ537186A (en) * 2002-06-20 2006-10-27 Novartis Consumer Health S Nasal compositions comprising a mucopolysaccharide and propylene glycol
CN1684701B (zh) 2002-07-30 2012-10-17 奥默罗斯公司 眼科冲洗液及方法
PT1545548E (pt) * 2002-08-30 2010-09-02 Nycomed Gmbh Utilização da combinação de ciclesonida e anti-histamínicos para o tratamento de rinite alérgica
US7714011B2 (en) * 2002-09-13 2010-05-11 Zicam, Llc Compositions to reduce congestion and methods for application thereof to the nasal membrane
US20040198828A1 (en) * 2003-01-17 2004-10-07 Abelson Mark B. Combinational use of long-acting and short-acting anti-histamines for ocular allergies
JP2010241834A (ja) * 2003-02-19 2010-10-28 Rohto Pharmaceut Co Ltd 医薬組成物
JP2007039473A (ja) * 2003-02-19 2007-02-15 Rohto Pharmaceut Co Ltd 医薬組成物
JP2005330245A (ja) * 2004-05-21 2005-12-02 Kowa Co 鼻炎用薬
DE102004049008A1 (de) * 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
ES2704482T3 (es) 2004-11-24 2019-03-18 Meda Pharmaceuticals Inc Composiciones que comprenden azelastina y sus métodos de uso
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
JP2009535342A (ja) * 2006-04-26 2009-10-01 アーシエックス， インコーポレイテッド 眼瞼腫脹の予防および処置のための組成物
US20090136598A1 (en) * 2006-04-26 2009-05-28 Aciex, Inc. Compositions for the Treatment and Prevention of Eyelid Swelling
US7378082B1 (en) 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
JP2008285474A (ja) * 2007-04-17 2008-11-27 Daiichi Sankyo Healthcare Co Ltd 抗アデノウイルス剤を含有する医薬組成物
US8952011B2 (en) 2008-08-01 2015-02-10 Eye Therapies Llc Compositions and methods for the treatment of nasal conditions
US20150119401A1 (en) * 2008-08-01 2015-04-30 Eye Therapies, Llc Compositions and Methods for the Treatment of Nasal Conditions
US20110257188A1 (en) * 2008-08-01 2011-10-20 Gerald Horn Compositions and methods for the treatment of nasal conditions
US20120156244A1 (en) * 2008-08-01 2012-06-21 Alpha Synergy Development Inc. Nasal Compositions and Uses Thereof
JP5671459B2 (ja) 2008-08-01 2015-02-18 アイ・セラピーズ・エル・エル・シー 血管収縮組成物および使用方法
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US9254286B2 (en) * 2009-03-17 2016-02-09 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US20120225918A1 (en) * 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
JP5752578B2 (ja) * 2011-12-09 2015-07-22 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Surgical (Ireland) Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
US11135155B2 (en) 2014-07-08 2021-10-05 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
WO2016068975A1 (en) * 2014-10-31 2016-05-06 Avon Products, Inc. Topical compositions and methods of use thereof
TWI705812B (zh) 2014-12-01 2020-10-01 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
DE102016125378A1 (de) * 2016-12-22 2018-06-28 Werner Schmidt Zusammensetzung zur Behandlung von Erkältungskrankheiten
RU2744097C2 (ru) * 2018-02-28 2021-03-02 Акционерное Общество "Вертекс" Комбинированное противоаллергическое лекарственное средство для назального применения

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822349A (en) * 1969-06-02 1974-07-02 C Kosti Vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue
JPH07188002A (ja) * 1993-12-27 1995-07-25 Taisho Pharmaceut Co Ltd 鼻炎治療用組成物

Also Published As

Publication number Publication date
DE19882573T1 (de) 2000-10-26
ES2171356B2 (es) 2004-05-01
ZA988638B (en) 1999-03-23
AU9540098A (en) 1999-04-12
PL339541A1 (en) 2000-12-18
CA2304162A1 (en) 1999-04-01
US20020037297A1 (en) 2002-03-28
JP2001517639A (ja) 2001-10-09
NO20001459D0 (no) 2000-03-21
EP0903151A1 (en) 1999-03-24
ES2171356A1 (es) 2002-09-01
BR9812361A (pt) 2000-09-19
WO1999015203A1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
NO20001459L (no) Anvendelse av kombinasjoner som innbefatter ikke-sedative antihistaminer og &lt;alfa&gt;-adrenerge legemidler for topisk behandling av rhinitt/konjunktivitt og forkjølelse, forskjølelseslignende og/eller influensasymptomer
NO20035323L (no) Strikket substrat for anvendelse i medisinsk bandasjeprodukt, bandasjeprodukt og fremgangsmåte for tilveiebringelse av det samme
DK0966454T3 (da) Disubstituerede bicykliske heterocykler, deres fremstilling og deres anvendelse som lægemidler
NO20023818D0 (no) Ny kombinasjon av ikke-beroligende antihistaminer med forbindelser som påvirker leukotrienvirkning for behandling avrhinitt/konjunktivitt
NO20034430D0 (no) Tiohydantoiner og anvendelse derav for behandling av diatbetes
NO20050427L (no) Carvedilolfosfatsalter og/eller solvater derav, tilsvarende preparater og/eller behandlingsfremgangsmater
NO991815L (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
ATE345133T1 (de) Laktose-freie, nicht-hygroskopische und wasserfreie pharmazeutische zusammensetzungen von descarboethoxyloratadin
NO20035120D0 (no) 4-(fenyl-(piperidin-4-yl)-amino)-benzamidderivater og deres anvendelse vedbehandling av angst, smerte eller gastrointestinale forstyrrelser
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
DE69728323D1 (de) Variante des humanen C3a Rezeptors; diagnostische und therapeutische Verwendungen
ID28050A (id) Alat kesehatan
NO994673D0 (no) Nye terapeutiske kombinasjoner av mirtazapin og antipsykotiske midler for behandling eller profylakse av psykotiske lidelser
NO20031806D0 (no) Anvendelse av pericytt apoptosehemmere for behandling og/eller forhindringav diabetisk retinopati
NO20041214L (no) Substituerte benzimidazolforbindelser og deres anvendelse for behandling av cancer
NO20022916D0 (no) System og fremgangsmåte for assistanse ved medisinsk behandling, og datamaskinprogram
NO993670D0 (no) Quinoksalin i trippelkombinasjon med proteaseinhibitorer og reverse transkriptaseinhibitorer som medikament for behandling av AIDS
ATE451934T1 (de) Pharmazeutische zusammensetzung zur behandlung von rhinitiden
NO20033228D0 (no) Anvendelse av IL-18 inhibitorer til behandling og/eller forhindring av hjertesykdom
NO20035115D0 (no) 4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser
NO20035117D0 (no) 4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser
NO20035118D0 (no) 4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser
NO20000229D0 (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO996264D0 (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO20020008L (no) Anvendelse av cortisol antagonister i behandling av hjertesvikt